Definitive Healthcare (NASDAQ:DH) Releases FY24 Earnings Guidance

Definitive Healthcare (NASDAQ:DH) updated its FY24 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of $0.36-$0.38 for the period, compared to the consensus estimate of $0.38. The company issued revenue guidance of $255-261 million, compared to the consensus revenue estimate of $266.31 million. Definitive Healthcare also updated its Q2 guidance to $0.08-$0.09 EPS.

Wall Street Analyst Weigh In

A number of research analysts have recently weighed in on the company. Barclays raised their price objective on Definitive Healthcare from $10.00 to $11.00 and gave the company an equal weight rating in a research report on Friday, March 1st. Needham & Company LLC lowered Definitive Healthcare from a buy rating to a hold rating in a research report on Wednesday, January 17th. Canaccord Genuity Group lifted their price target on Definitive Healthcare from $9.00 to $10.00 and gave the stock a hold rating in a research report on Thursday, February 29th. Finally, Stifel Nicolaus dropped their price target on Definitive Healthcare from $12.00 to $11.00 and set a buy rating for the company in a research report on Wednesday, January 17th. Seven investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, the stock has an average rating of Hold and an average target price of $11.31.

Definitive Healthcare Trading Down 1.2 %

NASDAQ DH traded down $0.09 during trading on Tuesday, hitting $7.25. The stock had a trading volume of 480,437 shares, compared to its average volume of 560,899. The company has a debt-to-equity ratio of 0.20, a quick ratio of 2.31 and a current ratio of 2.31. The stock has a market capitalization of $853.98 million, a price-to-earnings ratio of -4.07, a P/E/G ratio of 6.12 and a beta of 1.41. Definitive Healthcare has a one year low of $5.53 and a one year high of $12.45. The stock has a 50 day simple moving average of $7.82 and a 200 day simple moving average of $8.31.

Definitive Healthcare (NASDAQ:DH) last announced its quarterly earnings data on Wednesday, February 28th. The company reported ($0.01) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.01 by ($0.02). The firm had revenue of $65.93 million during the quarter, compared to the consensus estimate of $66.01 million. Definitive Healthcare had a positive return on equity of 0.43% and a negative net margin of 80.40%. Sell-side analysts predict that Definitive Healthcare will post 0.11 earnings per share for the current year.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.